A dual‐specific anti‐IGF‐1/IGF‐2 human monoclonal antibody alone and in combination with temsirolimus for therapy of neuroblastoma

Publisher: John Wiley & Sons Inc

E-ISSN: 1097-0215|137|9|2243-2252

ISSN: 0020-7136

Source: INTERNATIONAL JOURNAL OF CANCER, Vol.137, Iss.9, 2015-11, pp. : 2243-2252

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract